Last 7 days
-10.8%
Last 30 days
-13.9%
Last 90 days
-24.5%
Trailing 12 Months
42.6%
Datesorted ascending | Name | Buy/Sell | $ Value | Avg. Price | # Shares | Title |
---|---|---|---|---|---|---|
2023-09-14 | Saxonov Serge | gifted | - | - | -3,167 | chief executive officer |
2023-09-14 | Saxonov Serge | sold | -98,739 | 49.3697 | -2,000 | chief executive officer |
2023-08-22 | McAnear Justin J. | sold | -76,820 | 45.7811 | -1,678 | chief financial officer |
2023-08-22 | Saxonov Serge | sold | -172,000 | 45.7811 | -3,757 | chief executive officer |
2023-08-22 | Hindson Benjamin J. | sold | -157,899 | 45.7811 | -3,449 | see remarks |
2023-08-22 | Wilbur James | sold | -444,031 | 45.7811 | -9,699 | chief commercial officer |
2023-08-14 | Saxonov Serge | sold | -100,212 | 50.106 | -2,000 | chief executive officer |
2023-08-01 | Hindson Benjamin J. | sold | -433,612 | 62.2112 | -6,970 | see remarks |
2023-08-01 | Hindson Benjamin J. | acquired | 80,015 | 11.48 | 6,970 | see remarks |
2023-07-19 | Hindson Benjamin J. | acquired | 76,491 | 5.4872 | 13,940 | see remarks |
Datesorted ascending | Fund Name | Type | % Chg | $ Change | $ Held | % Portfolio |
---|---|---|---|---|---|---|
2023-09-20 | BARCLAYS PLC | added | 85.62 | 559,000 | 1,208,000 | -% |
2023-09-12 | Farther Finance Advisors, LLC | reduced | -94.94 | -55,452 | 2,960 | -% |
2023-08-22 | VIRGINIA RETIREMENT SYSTEMS ET AL | reduced | -34.39 | -300,751 | 575,152 | 0.01% |
2023-08-21 | OSAIC HOLDINGS, INC. | added | 64.00 | 1,099,900 | 2,803,720 | -% |
2023-08-21 | CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | added | 6.01 | 346,097 | 6,016,150 | 0.01% |
2023-08-21 | TEACHERS RETIREMENT SYSTEM OF THE STATE OF KENTUCKY | unchanged | - | 3,000 | 4,128,000 | 0.04% |
2023-08-21 | VitalStone Financial, LLC | unchanged | - | -1,000 | - | -% |
2023-08-16 | CASTLEARK MANAGEMENT LLC | new | - | 3,423,550 | 3,423,550 | 0.16% |
2023-08-16 | Nuveen Asset Management, LLC | reduced | -0.78 | -99,014 | 14,219,000 | -% |
2023-08-15 | PUBLIC EMPLOYEES RETIREMENT SYSTEM OF OHIO | reduced | -9.21 | -234,000 | 2,319,000 | 0.01% |
Date Filed | Name of Filer | Percent of Class | No. of Shares | Form Type | |
---|---|---|---|---|---|
Jul 10, 2023 | morgan stanley | 5.2% | 5,139,461 | SC 13G/A | |
Jul 10, 2023 | fmr llc | - | 0 | SC 13G/A | |
Feb 14, 2023 | venrock associates vi, l.p. | 4.9% | 4,828,247 | SC 13G/A | |
Feb 09, 2023 | fmr llc | - | 0 | SC 13G/A | |
Feb 09, 2023 | vanguard group inc | 8.81% | 8,420,011 | SC 13G/A | |
Feb 08, 2023 | morgan stanley | 10.4% | 9,894,979 | SC 13G/A | |
Feb 01, 2023 | blackrock inc. | 5.6% | 5,319,179 | SC 13G/A | |
Jan 18, 2023 | baillie gifford & co | 9.00% | 8,602,235 | SC 13G/A | |
Sep 12, 2022 | morgan stanley | 10.9% | 10,341,753 | SC 13G/A | |
May 09, 2022 | blackrock inc. | 10.9% | 10,227,673 | SC 13G |
Date Filed | Form Type | Document | |
---|---|---|---|
Sep 18, 2023 | 4 | Insider Trading | |
Sep 14, 2023 | 144 | Notice of Insider Sale Intent | |
Aug 24, 2023 | 4 | Insider Trading | |
Aug 24, 2023 | 4 | Insider Trading | |
Aug 24, 2023 | 4 | Insider Trading | |
Aug 24, 2023 | 4 | Insider Trading | |
Aug 16, 2023 | 4 | Insider Trading | |
Aug 04, 2023 | 10-Q | Quarterly Report | |
Aug 03, 2023 | 4 | Insider Trading | |
Aug 03, 2023 | 8-K | Current Report |
Name | Mkt Capsorted ascending | Revenue | Price %, 1M | Returns, 1Y | P/E | P/S | Rev 1-Yr | Inc 1-Yr |
---|---|---|---|---|---|---|---|---|
LARGE-CAP | ||||||||
A | 32.8B | 7.0B | -6.47% | -9.35% | 28.95 | 4.69 | 5.03% | -14.68% |
MTD | 24.5B | 4.0B | -4.51% | -0.85% | 27.61 | 6.21 | 2.30% | 16.37% |
ILMN | 20.8B | 4.5B | -16.87% | -30.97% | -4.96 | 4.65 | -4.92% | -21931.58% |
PKI | 16.1B | 2.8B | -15.95% | -22.45% | 19.74 | 5.69 | -24.31% | 21.35% |
WAT | 16.0B | 3.0B | -0.88% | -1.65% | 23.72 | 5.35 | 3.16% | -3.93% |
MID-CAP | ||||||||
SMALL-CAP | ||||||||
PACB | 2.1B | 146.1M | -14.72% | 60.53% | -6.64 | 14.5 | 4.72% | -55.19% |
QTRX | 974.5M | 112.0M | 4.60% | 206.26% | -14.81 | 8.7 | 0.83% | 16.42% |
ADPT | 734.8M | 189.6M | -17.53% | -21.85% | -3.85 | 3.88 | 18.74% | 17.75% |
HBIO | 174.6M | 114.1M | -5.10% | 58.53% | -32.16 | 1.53 | -5.49% | -48.58% |
CDXS | 104.7M | 99.2M | -9.09% | -75.61% | -1.85 | 1.06 | -26.56% | -199.52% |
BNGO | 99.1M | 31.5M | -3.25% | 60.22% | -0.68 | 3.14 | 35.12% | -38.47% |
NSTG | 78.4M | 143.9M | -41.49% | -87.32% | -0.47 | 0.54 | 0.71% | -18.99% |
CSBR | 72.9M | 52.7M | -18.03% | -31.52% | -9.65 | 1.38 | 2.10% | -1984.29% |
PSNL | 59.2M | 67.1M | -18.67% | -60.39% | -0.54 | 0.88 | -12.13% | -17.68% |
-30.8%
88.3%
65.7%
59.6%
Y-axis is the maximum loss one would have experienced if 10x Genomics was unfortunately bought at previous high price.
Income Statement (Last 12 Months) | ||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Description | (%) Q/Q | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 | 2018Q4 | 2018Q3 | 2018Q2 |
Revenue | 6.0% | 568,408,000 | 536,198,000 | 516,409,000 | 503,707,000 | 497,932,000 | 499,165,000 | 490,490,000 | 459,178,000 | 405,698,000 | 332,761,000 | 298,845,000 | 261,916,000 | 251,306,000 | 264,220,000 | 245,893,000 | 221,158,000 | 196,558,000 | 172,483,000 | 146,313,000 | 127,678,667 | 118,304,000 |
Gross Profit | 3.1% | 418,102,000 | 405,395,000 | 396,023,000 | 392,550,000 | 392,634,000 | 416,656,000 | 416,399,000 | 393,788,000 | 350,415,000 | 272,341,000 | 240,377,000 | 205,763,000 | 194,084,000 | 202,044,000 | 184,860,000 | 161,807,000 | 147,446,000 | 133,827,000 | 117,652,000 | 109,330,667 | 101,264,000 |
Operating Expenses | 2.2% | 596,540,000 | 583,592,000 | 563,967,000 | 553,228,000 | 529,195,000 | 500,428,000 | 468,652,000 | 839,794,000 | 845,797,000 | 796,815,000 | 774,519,000 | 338,402,000 | 270,564,000 | 249,466,000 | 215,433,000 | 259,265,000 | 250,741,000 | 266,088,000 | 228,416,000 | 185,196,000 | - |
S&GA Expenses | 3.9% | 327,078,000 | 314,905,000 | 298,300,000 | 289,290,000 | 277,965,000 | 267,331,000 | 257,560,000 | 243,657,000 | 233,130,000 | 208,843,000 | 202,326,000 | 185,108,000 | 166,173,000 | 154,328,000 | 130,834,000 | 118,984,000 | 105,480,000 | 97,212,000 | 87,936,000 | 76,440,000 | - |
EBITDA | 100.0% | - | -143,905,000 | -136,127,000 | -136,357,000 | -113,325,000 | -60,963,000 | -31,731,000 | -426,124,000 | -476,665,000 | -507,931,000 | -518,782,000 | -117,583,000 | -63,155,000 | -36,000,000 | -20,888,000 | -91,603,000 | -98,403,666 | -119,324,000 | -106,084,000 | -54,660,000 | -13,625,000 |
EBITDA Margin | 100.0% | - | -0.27 | -0.26 | -0.27 | -0.23 | -0.12 | -0.06 | -0.93 | -1.17 | -1.53 | -1.74 | -0.45 | -0.25 | -0.14 | -0.08 | -0.41 | -0.50 | -0.69 | -0.73 | -0.43 | -0.12 |
Interest Expenses | -28.3% | 263,000 | 367,000 | 476,000 | 568,000 | 673,000 | 773,000 | 866,000 | 966,000 | 1,144,000 | 1,241,000 | 1,682,000 | 2,357,000 | 2,668,000 | 3,057,000 | 3,079,000 | 2,775,000 | 2,726,000 | 2,708,000 | 2,409,000 | 2,636,000 | - |
Earnings Before Taxes | 1.8% | -166,867,000 | -169,931,000 | -161,971,000 | -161,553,000 | -138,166,000 | -84,293,000 | -53,715,000 | -446,345,000 | -494,960,000 | -524,747,000 | -534,476,000 | -132,879,000 | -77,211,000 | -48,276,000 | -31,033,000 | -99,489,000 | -105,223,000 | -125,884,000 | -112,398,000 | -61,316,000 | - |
EBT Margin | 100.0% | - | -0.32 | -0.31 | -0.32 | -0.28 | -0.17 | -0.11 | -0.97 | -1.22 | -1.58 | -1.79 | -0.51 | -0.31 | -0.18 | -0.13 | -0.45 | -0.54 | -0.73 | -0.77 | -0.48 | -0.16 |
Net Income | 1.2% | -172,290,000 | -174,334,000 | -166,000,000 | -167,234,000 | -142,491,000 | -89,085,000 | -58,223,000 | -455,347,000 | -504,024,000 | -533,139,000 | -542,731,000 | -134,292,000 | -78,047,000 | -48,758,000 | -31,251,000 | -99,641,000 | -105,383,000 | -100,428,000 | -112,485,000 | -49,281,333 | -43,232,000 |
Net Income Margin | 100.0% | - | -0.33 | -0.32 | -0.33 | -0.29 | -0.18 | -0.12 | -0.99 | -1.24 | -1.60 | -1.82 | -0.51 | -0.31 | -0.18 | -0.13 | -0.45 | -0.54 | -0.58 | -0.77 | -0.39 | -0.37 |
Free Cashflow | 100.0% | - | -125,013,000 | -165,267,000 | -161,069,000 | -161,376,000 | -128,642,000 | -122,651,000 | -252,352,000 | -262,047,000 | -286,856,000 | -254,564,000 | -102,906,000 | -45,920,000 | -18,721,000 | -8,115,000 | -61,662,000 | -83,346,666 | -106,904,000 | -82,693,000 | -39,053,333 | -14,455,000 |
Balance Sheet | (In Millions) | |||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Description | (%) Q/Q | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2018Q4 |
Assets | -2.4% | 990 | 1,014 | 1,029 | 996 | 1,002 | 1,003 | 1,019 | 991 | 978 | 954 | 929 | 1,043 | 583 | 610 | 46.00 | 573 | 124 |
Current Assets | -3.1% | 583 | 602 | 635 | 629 | 666 | 697 | 748 | 744 | 757 | 746 | 774 | 900 | 452 | 430 | 481 | 474 | 106 |
Cash Equivalents | -2.6% | 331 | 340 | 227 | 242 | 282 | 320 | 596 | 609 | 649 | 644 | 689 | 834 | 404 | 432 | 476 | 477 | 70.00 |
Inventory | 1.7% | 84.00 | 82.00 | 82.00 | 79.00 | 71.00 | 64.00 | 60.00 | 51.00 | 44.00 | 39.00 | 30.00 | 25.00 | 22.00 | 19.00 | 15.00 | 13.00 | 9.00 |
Net PPE | -2.5% | 285 | 292 | 289 | 258 | 223 | 190 | 169 | 143 | 122 | 107 | 73.00 | 65.00 | 56.00 | 52.00 | 49.00 | 47.00 | 11.00 |
Goodwill | 0% | 5.00 | 5.00 | 5.00 | 5.00 | 5.00 | 5.00 | 5.00 | 5.00 | 5.00 | 5.00 | 5.00 | - | - | - | - | - | - |
Liabilities | -7.2% | 196 | 212 | 223 | 220 | 218 | 197 | 201 | 190 | 193 | 202 | 190 | 217 | 192 | 201 | 186 | 151 | 101 |
Current Liabilities | -12.4% | 98.00 | 112 | 131 | 127 | 118 | 94.00 | 110 | 100 | 113 | 121 | 118 | 146 | 122 | 59.00 | 63.00 | 48.00 | 32.00 |
LT Debt, Current | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 10.00 | 7.00 | 4.00 |
LT Debt, Non Current | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 20.00 | 22.00 | 25.00 |
Shareholder's Equity | -1.1% | 793 | 802 | 806 | 776 | 784 | 807 | 818 | 800 | 785 | 752 | 739 | 825 | 391 | 409 | 420 | 421 | - |
Retained Earnings | -5.8% | -1,142 | -1,080 | -1,029 | -1,012 | -970 | -905 | -863 | -844 | -827 | -816 | -805 | -389 | -323 | -283 | -262 | -255 | -231 |
Additional Paid-In Capital | 2.8% | 1,937 | 1,884 | 1,839 | 1,793 | 1,758 | 1,715 | 1,681 | 1,645 | 1,612 | 1,569 | 1,544 | 1,215 | 715 | 693 | 682 | 677 | 11.00 |
Accumulated Depreciation | - | 86.00 | - | 69.00 | - | - | - | 49.00 | 44.00 | 39.00 | 35.00 | 31.00 | - | - | - | 19.00 | - | 14.00 |
Shares Outstanding | 0.9% | 117 | 116 | 115 | 114 | 114 | 113 | 113 | 111 | 110 | 109 | 108 | 101 | 99.00 | 97.00 | 96.00 | 20.00 | 13.00 |
Cashflow (Last 12 Months) | (In Millions) | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Description | (%) Q/Q | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 | 2018Q4 | 2018Q3 | 2017Q4 |
Cashflow From Operations | 32.1% | -11.49 | -16.93 | -33.61 | -41.52 | -58.18 | -38.09 | -21.37 | -157 | -186 | -219 | -217 | -81.02 | -10.87 | 23.00 | 35.00 | -23.07 | -50.13 | -83.36 | -76.41 | -33.88 | -10.70 |
Share Based Compensation | 6.1% | 162 | 153 | 137 | 123 | 115 | 106 | 96.00 | 83.00 | 71.00 | 58.00 | 49.00 | 39.00 | 30.00 | 19.00 | 13.00 | 9.00 | 6.00 | 4.00 | 3.00 | 2.00 | 2.00 |
Cashflow From Investing | 86.6% | 50.00 | 27.00 | -350 | -345 | -332 | -319 | -106 | -101 | -82.46 | -74.63 | -38.39 | -22.71 | -35.08 | -41.48 | -42.77 | -39.01 | -33.78 | -24.39 | -6.71 | -5.17 | -3.76 |
Cashflow From Financing | 7.4% | 11.00 | 10.00 | 16.00 | 20.00 | 24.00 | 34.00 | 35.00 | 34.00 | 514 | 506 | 469 | 460 | 389 | 380 | 415 | 452 | 48.00 | 74.00 | 105 | 93.00 | 21.00 |
Condensed Consolidated Statements of Operations - USD ($) $ in Thousands | 3 Months Ended | 6 Months Ended | ||
---|---|---|---|---|
Jun. 30, 2023 | Jun. 30, 2022 | Jun. 30, 2023 | Jun. 30, 2022 | |
Income Statement [Abstract] | ||||
Revenue | $ 146,819 | $ 114,609 | $ 281,104 | $ 229,105 |
Cost of revenue | 47,207 | 27,704 | 83,102 | 53,182 |
Gross profit | 99,612 | 86,905 | 198,002 | 175,923 |
Operating expenses: | ||||
Research and development | 71,460 | 70,685 | 138,558 | 134,763 |
Selling, general and administrative | 91,510 | 79,337 | 174,790 | 146,012 |
Total operating expenses | 162,970 | 150,022 | 313,348 | 280,775 |
Loss from operations | (63,358) | (63,117) | (115,346) | (104,852) |
Other income (expense): | ||||
Interest income | 4,100 | 1,238 | 7,969 | 1,807 |
Interest expense | (5) | (109) | (24) | (237) |
Other expense, net | (1,504) | (1,843) | (3,020) | (2,243) |
Total other income (expense) | 2,591 | (714) | 4,925 | (673) |
Loss before provision for income taxes | (60,767) | (63,831) | (110,421) | (105,525) |
Provision for income taxes | 1,647 | 627 | 2,740 | 1,346 |
Net loss | $ (62,414) | $ (64,458) | $ (113,161) | $ (106,871) |
Net loss per share, basic (in dollars per share) | $ (0.53) | $ (0.57) | $ (0.97) | $ (0.94) |
Net loss per share, diluted (in dollars per share) | $ (0.53) | $ (0.57) | $ (0.97) | $ (0.94) |
Weighted-average shares of common stock used in computing net loss per share, basic (in shares) | 116,707,672 | 113,574,757 | 116,166,776 | 113,272,158 |
Weighted-average shares of common stock used in computing net loss per share, diluted (in shares) | 116,707,672 | 113,574,757 | 116,166,776 | 113,272,158 |
Condensed Consolidated Balance Sheets - USD ($) $ in Thousands | Jun. 30, 2023 | Dec. 31, 2022 |
---|---|---|
Current assets: | ||
Cash and cash equivalents | $ 325,879 | $ 219,746 |
Marketable securities | 65,506 | 210,238 |
Restricted cash | 1,500 | 2,633 |
Accounts receivable, net | 87,685 | 104,211 |
Inventory | 83,687 | 81,629 |
Prepaid expenses and other current assets | 18,683 | 16,578 |
Total current assets | 582,940 | 635,035 |
Property and equipment, net | 284,913 | 289,328 |
Restricted cash | 3,474 | 4,974 |
Operating lease right-of-use assets | 71,049 | 69,882 |
Goodwill | 4,511 | 4,511 |
Intangible assets, net | 22,290 | 22,858 |
Other noncurrent assets | 20,461 | 2,392 |
Total assets | 989,638 | 1,028,980 |
Current liabilities: | ||
Accounts payable | 23,124 | 21,599 |
Accrued compensation and related benefits | 22,372 | 32,675 |
Accrued expenses and other current liabilities | 34,088 | 59,779 |
Deferred revenue | 9,217 | 7,867 |
Operating lease liabilities | 9,286 | 9,037 |
Total current liabilities | 98,087 | 130,957 |
Operating lease liabilities, noncurrent | 90,331 | 86,139 |
Other noncurrent liabilities | 7,919 | 6,141 |
Total liabilities | 196,337 | 223,237 |
Commitments and contingencies (Note 4) | ||
Stockholders’ equity: | ||
Preferred stock | 0 | 0 |
Common stock | 2 | 2 |
Additional paid-in capital | 1,936,750 | 1,839,397 |
Accumulated deficit | (1,142,482) | (1,029,321) |
Accumulated other comprehensive loss | (969) | (4,335) |
Total stockholders’ equity | 793,301 | 805,743 |
Total liabilities and stockholders’ equity | $ 989,638 | $ 1,028,980 |